Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pasithea Therapeutics Corp shares valued at $798 were purchased by Tiago Reis Marques on May 12 ’25. At $0.83 per share, Tiago Reis Marques acquired 960 shares.
Also, Marques Tiago sold 960 shares, netting a total of over 792 in proceeds. Following the sale of shares at $0.82 each, the insider now holds 40,001 shares.
Analyzing KTTA Stock Performance
On last trading session,, Pasithea Therapeutics Corp [NASDAQ: KTTA] plunged -3.05% to $0.77. The stock’s lowest price that day was $0.76, but it reached a high of $0.78 in the same session. During the last five days, there has been a drop of approximately -8.76%. Over the course of the year, Pasithea Therapeutics Corp shares have dropped approximately -75.41%. Shares of the company reached a 52-week high of $3.8500 on 02/05/25 and a 52-week low of $0.7101 on 06/16/25.
Support And Resistance Levels for Pasithea Therapeutics Corp (KTTA)
According to the 24-hour chart, there is a support level at 0.7631, which, if violated, would cause prices to drop to 0.7515. In the upper region, resistance lies at 0.7831. The next price resistance is at 0.7915. RSI (Relative Strength Index) is 33.84 on the 14-day chart, showing neutral technical sentiment.
Is Pasithea Therapeutics Corp subject to short interest?
Stocks of Pasithea Therapeutics Corp saw a sharp rise in short interest on 2025-05-30 jumping by 0.19 million shares to 0.24 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 44258.0 shares. A jump of 81.24% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.02 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.02.
